|
Index of reports
> Cases resulting in life threatening events (58)
> Cases with Hepatic Function Abnormal (9)
Below is the selection of adverse event reports related to Crestor (Rosuvastatin) that includes cases resulting in life threatening events where reactions include hepatic function abnormal.
Adverse event in male receiving Crestor (Rosuvastatin)
Reported by a physician from Japan on 2007-07-31
Patient: male
Adverse reactions / side effects: Hepatic Function Abnormal, Malaise, Anorexia, Disseminated Intravascular Coagulation, Pleural Effusion, Apallic Syndrome, Ascites
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Crestor (Rosuvastatin)
Other drugs received by patient: Lipitor; Pravastatin
Adverse event in male receiving Crestor (Rosuvastatin)
Reported by a physician from Japan on 2007-07-26
Patient: male
Adverse reactions / side effects: Hepatic Function Abnormal, Anorexia, Disseminated Intravascular Coagulation, Pleural Effusion, Apallic Syndrome, Respiration Abnormal, Ascites
Adverse event resulted in: life threatening event
Suspect drug(s):
Crestor (Rosuvastatin)
Other drugs received by patient: Lipitor; Pravastatin
Adverse event in male receiving Crestor (Rosuvastatin)
Reported by a physician from Japan on 2007-07-25
Patient: male
Adverse reactions / side effects: Hepatic Function Abnormal, Drug Ineffective, Disseminated Intravascular Coagulation, General Physical Health Deterioration, Apallic Syndrome, Ascites, Cholangitis, Anorexia, Pleural Effusion, Respiration Abnormal
Adverse event resulted in: life threatening event
Suspect drug(s):
Crestor (Rosuvastatin)
Other drugs received by patient: Lipitor; Pravastatin
Adverse event in male receiving Crestor (Rosuvastatin)
Reported by a physician from Japan on 2007-06-18
Patient: male, weighing 60.2 kg (132.4 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dyspnoea, Cellulitis, Hepatic Function Abnormal, Visual Field Defect, Alanine Aminotransferase Increased, Hemiparesis, Dysarthria, Cardiac Failure, Cerebral Infarction, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Coronary Artery Restenosis, Aspartate Aminotransferase Increased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2005-12-21
End date: 2006-03-02
Crestor
Administration route: Oral
Start date: 2006-03-28
End date: 2006-07-03
Crestor
Administration route: Oral
Start date: 2006-07-04
End date: 2006-12-03
Other drugs received by patient: NU-Lotan; Allopurinol; Omepral; Euglucon; Cardenalin; Amlodin; Ticlopidine HCL; Prorenal; Sigmart; Aspirin; Pursennid; Mevalotin; Nitorol; Nitroderm; Albuminar; Predopa; Liple; Alprostadil; Metilon; Lasix; Mucodyne; Bisolvon; Hanp; Perdipine; Cefamezin Alpha
Adverse event in female receiving Crestor (Rosuvastatin)
Reported by a physician from Japan on 2007-03-08
Patient: female
Adverse reactions / side effects: Hepatic Function Abnormal, Cardiac Failure
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Crestor (Rosuvastatin)
Other drugs received by patient: Mevalotin; Norvasc; Amaryl; Olmetec
Adverse event in female receiving Crestor (Rosuvastatin)
Reported by a physician from Japan on 2007-02-19
Patient: female
Adverse reactions / side effects: Hepatic Function Abnormal, Cardiac Failure
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Crestor (Rosuvastatin)
Other drugs received by patient: Mevalotin; Norvasc; Amaryl; Olmetec
Adverse event in male receiving Crestor (Rosuvastatin)
Reported by a physician from Japan on 2007-02-07
Patient: male, weighing 60.2 kg (132.4 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dyspnoea, Cellulitis, Hepatic Function Abnormal, Visual Field Defect, Alanine Aminotransferase Increased, Hemiparesis, Dysarthria, Cardiac Failure, Cerebral Infarction, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Coronary Artery Restenosis, Aspartate Aminotransferase Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2005-12-21
End date: 2006-03-02
Crestor
Administration route: Oral
Start date: 2006-03-28
End date: 2006-07-03
Crestor
Administration route: Oral
Start date: 2006-07-04
End date: 2006-12-03
Other drugs received by patient: NU-Lotan; Zyloric; Omepral; Euglucon; Cardenalin; Amlodipine Besylate; Panaldine; Prorenal; Sigmart; Aspirin; Pursennid; Mevalotin; Nitorol; Nitroderm; Albuminar; Predopa; Liple; Alprostadil; Metilon; Lasix; Mucodyne; Bisolvon; Hanp; Perdipine; Cefamezin Alpha
Adverse event in female receiving Crestor (Rosuvastatin)
Reported by a physician from Japan on 2007-02-05
Patient: female
Adverse reactions / side effects: Hepatic Function Abnormal, Cardiac Failure
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Crestor (Rosuvastatin)
Other drugs received by patient: Mevalotin; Norvasc; Amaryl; Olmetec
Adverse event in male receiving Crestor (Rosuvastatin)
Reported by a physician from Japan on 2007-01-30
Patient: male, weighing 60.2 kg (132.4 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dyspnoea, Cellulitis, Hepatic Function Abnormal, Visual Field Defect, Alanine Aminotransferase Increased, Hemiparesis, Dysarthria, Cardiac Failure, Cerebral Infarction, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Coronary Artery Restenosis, Aspartate Aminotransferase Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2005-12-21
End date: 2006-03-02
Crestor
Administration route: Oral
Start date: 2006-03-28
End date: 2006-07-03
Crestor
Administration route: Oral
Start date: 2006-07-04
End date: 2006-12-03
Other drugs received by patient: NU-Lotan; Zyloric; Omepral; Euglucon; Cardenalin; Amlodipine Besylate; Panaldine; Prorenal; Sigmart; Aspirin; Pursennid; Mevalotin; Nitorol; Nitroderm; Albuminar; Predopa; Liple; Alprostadil; Metilon; Lasix; Mucodyne; Bisolvon; Hanp; Perdipine; Cefamezin Alpha
|
